ESC 2021: MASTER-DAPT Indicates 1 Month of Dual Antiplatelet Therapy Is Enough After Percutaneous Coronary Intervention
Patients were all at high risk of bleeding and received a drug-eluting stent
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.